Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 66-69

  Crump, M ^a   Goss, P E ^a   Prince, M ^a   Girouard, C ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030070377     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.66     Document Type: Article

References (21)

1. Early Breast Cancer Trialist's Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:1-15, 71-85, 1992
2. Jones SE, Moon TE, Bonadonna G, et al: Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base. Am J Clin Oncol 10:387-395, 1987
3. Bonadonna G, Valagussa P, Moliterni A et al: Adjuvant cyclophosphamide, methotrexate and fluorouracil in node positive breast cancer: The results of 20 years of follow-up. N Engl J Med 332:901 - 906, 1995
4. Abeloff MD, Beveridge RA, Donehower RC, et al: Sixteen-week dose-intensive chemotherapy in the adjuvant treatment of breast cancer. J Natl Cancer Inst 82:570-574, 1990
5. Cascinelli N, Greco M, Morabito A, et al: Comparison of long-term survival of 1986 consecutive patients with breast cancer treated at the National Institute of Cancer of Milano, Italy (1971 to 1972 and 1977 to 1978). Cancer 68:427-434, 1991
6. Buzdar AU, Kau SW, Hortobagyi GN, et al: Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy. Cancer 69:448-452, 1992
7. Bonadonna G, Zambeti M, Valagussa P: Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive lymph nodes: Ten year results. JAMA 273:542-547, 1995
8. Peters WP, Ross M, Vredenburgh JJ, et al: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132-1143, 1993
9. Gianni AM, Siena S, Bregni M, et al: Growth factor-supported high-dose sequential (HDS) adjuvant chemotherapy in breast cancer with ≥ 10 positive nodes. Proc Am Soc Clin Oncol 11:61, 1992 (abstr 68)
10. Peters WP, Berry D, Vredenburgh JJ, et al: Five year follow-up of high-dose combination alkylating agents with ABMT as consolidation after standard-dose CAF for primary breast cancer involving ≥ 10 axillary lymph nodes (Duke/CALGB 8782). Proc Am Soc Clin Oncol 14:316, 1995 (abstr 933)
11. Gianni AM, Siena S, Bregni M, et al: Five year results of high-dose sequential (HDS) adjuvant chemotherapy in breast cancer with ≥ 10 positive nodes. Proc Am Soc Clin Oncol 14:90, 1995 (abstr 61)
12. Antman KS, Rowlings PA, Horowitz MM, et al: Autotransplants for Breast Cancer in North America, in Dicke KA, Keating A (eds): Autologous Marrow and Blood Transplantation: Proceedings of the Seventh International Symposium. Arlington, TX, Cancer Treatment Research and Educational Institute, 1995, p 187
13. Levine M, Bramwell V, Bowman D, et al: A clinical trial of intensive CEF versus CMF in premenopausal women with node positive breast cancer. Proc Am Soc Clin Oncol 14:103, 1995 (abstr 112)
14. Baker RR: Preoperative assessment of patients with breast cancer. Surg Clin North Am 64:1039-1050, 1984
15. Feig SA: The role of new imaging modalities in staging and follow-up of breast cancer. Semin Oncol 13:402-414, 1986
16. Mansi JL, Easton D, Berger U, et al: Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up Eur J Cancer 27:1552-1555, 1991
17. Sanal SM, Flickinger FW, Caudell MJ, et al: Detection of bone marrow involvement in breast cancer with magnetic resonance imaging. J Clin Oncol 12:1415-1421, 1994
18. Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604-1608, 1985
19. Tormey DC, Weinberg VE, Holland JF, et al: A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer. J Clin Oncol 1:138-145, 1983
20. Lichtman SM, Budman D, Bosworth S, et al: Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. Am J Clin Oncol 14:317-321, 1991
21. Wood WC, Budman DR, Korzun AH, et al: Dose and dose intensity of adjuvant chemotherapy for stage II, node positive breast carcinoma. N Engl J Med 330:1253-1259, 1994